Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles H Hennekens

Showing results (1-10 of 262) with videos related to

Pageof 27
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 7, 2008
Fixed-dose combination therapy with statins: strengths, limitations, and clinical and regulatory considerationsCharles H Hennekens
The American Journal of Medicine|December 31, 2008
Statin-induced myopathy: hypothesis about randomized evidence and clinical impressionsCharles H Hennekens
Clinical Chemistry|July 2, 2011
Aspirin in the primary prevention of myocardial infarctionCharles H Hennekens
The American Journal of Managed Care|January 7, 2003
Update on aspirin in the treatment and prevention of cardiovascular diseaseCharles H Hennekens
Current Atherosclerosis Reports|November 16, 2007
Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directionsCharles H Hennekens
The American Journal of Medicine|February 12, 2021
Reflections to My Beloved Grandchildren for the New Year 2021Charles H Hennekens
Annals of Epidemiology|April 4, 2006
Sir Richard Doll, 1912 to 2005: a tribute and personal remembranceCharles H Hennekens
Current Atherosclerosis Reports|December 10, 2003
The ALLHAT-LLT and ASCOT-LLA trials: are the discrepancies more apparent than real?Charles H Hennekens
CNS Spectrums|October 22, 2008
Prevention of premature mortality among patients with schizophrenia: the need for primary prevention efforts in cardiovascular diseaseCharles H Hennekens
The Journal of Clinical Psychiatry|August 19, 2007
Increasing global burden of cardiovascular disease in general populations and patients with schizophreniaCharles H Hennekens
Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 7, 2008
Fixed-dose combination therapy with statins: strengths, limitations, and clinical and regulatory considerationsCharles H Hennekens
The American Journal of Medicine|December 31, 2008
Statin-induced myopathy: hypothesis about randomized evidence and clinical impressionsCharles H Hennekens
Clinical Chemistry|July 2, 2011
Aspirin in the primary prevention of myocardial infarctionCharles H Hennekens
The American Journal of Managed Care|January 7, 2003
Update on aspirin in the treatment and prevention of cardiovascular diseaseCharles H Hennekens
Current Atherosclerosis Reports|November 16, 2007
Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directionsCharles H Hennekens
The American Journal of Medicine|February 12, 2021
Reflections to My Beloved Grandchildren for the New Year 2021Charles H Hennekens
Annals of Epidemiology|April 4, 2006
Sir Richard Doll, 1912 to 2005: a tribute and personal remembranceCharles H Hennekens
Current Atherosclerosis Reports|December 10, 2003
The ALLHAT-LLT and ASCOT-LLA trials: are the discrepancies more apparent than real?Charles H Hennekens
CNS Spectrums|October 22, 2008
Prevention of premature mortality among patients with schizophrenia: the need for primary prevention efforts in cardiovascular diseaseCharles H Hennekens
The Journal of Clinical Psychiatry|August 19, 2007
Increasing global burden of cardiovascular disease in general populations and patients with schizophreniaCharles H Hennekens
Pageof 27